• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与免疫球蛋白G共价结合的补体3b显示出被H因子和I因子灭活的速率降低。

C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.

作者信息

Fries L F, Gaither T A, Hammer C H, Frank M M

出版信息

J Exp Med. 1984 Dec 1;160(6):1640-55. doi: 10.1084/jem.160.6.1640.

DOI:10.1084/jem.160.6.1640
PMID:6239898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2187521/
Abstract

We have prepared C3b covalently linked to IgG via a hydroxylamine-sensitive bond between the C3b alpha' chain and sites predominantly, but not exclusively, located in the IgG heavy chain. This C3b species displays relative resistance to inactivation by factors H and I when compared with free C3b. This resistance appears to be due entirely to reduced affinity of C3b-IgG for factor H. Resistance to inactivation is not conferred on C3b by binding to another serum glycoprotein of similar size, ceruloplasmin, and may be a special property of IgG. C3b-IgG demonstrates an enhanced capacity to consume serum C3 relative to C3b. These alterations of the behavior of C3b when bound to IgG may in part explain the augmentation of alternative pathway activity by IgG. In addition, IgG-induced protection of C3b might influence both complement-mediated killing and phagocytosis of bacteria, as well as modify the in vivo handling of IgG-containing soluble immune complexes.

摘要

我们制备了通过C3bα′链与主要但并非仅位于IgG重链上的位点之间的对羟胺敏感的键共价连接到IgG的C3b。与游离C3b相比,这种C3b物种对因子H和I的失活表现出相对抗性。这种抗性似乎完全是由于C3b-IgG对因子H的亲和力降低。与大小相似的另一种血清糖蛋白铜蓝蛋白结合并不会赋予C3b失活抗性,这可能是IgG的一种特殊性质。相对于C3b,C3b-IgG表现出增强的消耗血清C3的能力。C3b与IgG结合时其行为的这些改变可能部分解释了IgG对替代途径活性的增强作用。此外,IgG诱导的对C3b的保护可能会影响补体介导的细菌杀伤和吞噬作用,以及改变含IgG的可溶性免疫复合物在体内的处理方式。

相似文献

1
C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.与免疫球蛋白G共价结合的补体3b显示出被H因子和I因子灭活的速率降低。
J Exp Med. 1984 Dec 1;160(6):1640-55. doi: 10.1084/jem.160.6.1640.
2
Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.CR1的I因子辅助因子活性克服了IgG对共价结合的C3b残基的保护作用。
J Immunol. 1985 Oct;135(4):2673-9.
3
The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.在人血清中替代途径激活后,补体成分C3与抗体 - 抗原聚集体的结合。
Biochem J. 1981 May 1;195(2):471-80. doi: 10.1042/bj1950471.
4
Studies on the mechanism of C3b inhibition of immune complex induced C1 activation.C3b对免疫复合物诱导的C1激活的抑制机制研究。
Mol Immunol. 1988 Dec;25(12):1339-46. doi: 10.1016/0161-5890(88)90049-1.
5
Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.克氏锥虫锥鞭毛体对替代补体途径溶解作用的抗性机制:特异性单克隆抗体的影响
J Immunol. 1986 Sep 1;137(5):1623-8.
6
C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.C3b2-IgG复合物在各个失活水平上都保留二聚体C3片段。
J Biol Chem. 2003 Dec 19;278(51):51806-12. doi: 10.1074/jbc.M304613200. Epub 2003 Oct 3.
7
Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).因子I和膜辅因子蛋白(MCP)对替代补体途径C5转化酶的优先灭活作用。
Mol Immunol. 1991 Oct;28(10):1137-47. doi: 10.1016/0161-5890(91)90029-j.
8
Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I.补体调节蛋白H因子和I因子对C3b调控的动力学和热力学分析。
Biochemistry. 1983 Jan 4;22(1):178-85. doi: 10.1021/bi00270a026.
9
Formation of covalently linked C3-C3 dimers on IgG immune aggregates.IgG免疫聚集体上共价连接的C3-C3二聚体的形成。
Eur J Immunol. 1991 Feb;21(2):343-9. doi: 10.1002/eji.1830210215.
10
Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.C3b₂-IgG复合物与补体蛋白备解素、B因子和H因子的相互作用:对补体放大的影响
Biochem J. 2000 Jul 1;349(Pt 1):217-23. doi: 10.1042/0264-6021:3490217.

引用本文的文献

1
Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.低接枝聚乙二醇水平的脂质体仍然容易受到抗聚乙二醇抗体的破坏。
ACS Nano. 2024 Aug 20;18(33):22122-22138. doi: 10.1021/acsnano.4c05409. Epub 2024 Aug 9.
2
Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles.调控纳米颗粒补体反应的纳米级和埃级特征。
J Control Release. 2022 Nov;351:432-443. doi: 10.1016/j.jconrel.2022.09.039. Epub 2022 Sep 27.
3
The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System.富含多价IgM/IgA的免疫球蛋白制剂在激活和抑制补体系统中的双重作用
Biomedicines. 2021 Jul 14;9(7):817. doi: 10.3390/biomedicines9070817.
4
Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.补体抑制剂可阻断补体 C3 调理作用,提高血液中纳米颗粒的靶向选择性。
Bioconjug Chem. 2020 Jul 15;31(7):1844-1856. doi: 10.1021/acs.bioconjchem.0c00342. Epub 2020 Jun 29.
5
Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant.利用葡萄球菌免疫逃逸蛋白 Sbi 作为新型疫苗佐剂。
Front Immunol. 2019 Jan 11;9:3139. doi: 10.3389/fimmu.2018.03139. eCollection 2018.
6
Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles.免疫球蛋白在生物分子冠上的沉积决定了临床前和临床纳米颗粒的补体调理效率。
Nat Nanotechnol. 2019 Mar;14(3):260-268. doi: 10.1038/s41565-018-0344-3. Epub 2019 Jan 14.
7
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?备解素途径:C3 和 C5 激活的“替代激活途径”还是“关键扩增环”?
Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22.
8
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.利用补体逃避策略设计基于补体的抗菌免疫疗法:来自致病性奈瑟菌的经验教训。
Immunobiology. 2016 Oct;221(10):1110-23. doi: 10.1016/j.imbio.2016.05.016. Epub 2016 Jun 1.
9
Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein.人对脑膜炎球菌因子H结合蛋白抗体反应的功能分析
mBio. 2015 Jun 23;6(3):e00842. doi: 10.1128/mBio.00842-15.
10
Meningococcal disease and the complement system.脑膜炎球菌病与补体系统。
Virulence. 2014 Jan 1;5(1):98-126. doi: 10.4161/viru.26515. Epub 2013 Oct 8.

本文引用的文献

1
The physiological breakdown of the third component of human complement.人类补体第三成分的生理分解。
Mol Immunol. 1980 Jan;17(1):9-20. doi: 10.1016/0161-5890(80)90119-4.
2
The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.在人血清中替代途径激活后,补体成分C3与抗体 - 抗原聚集体的结合。
Biochem J. 1981 May 1;195(2):471-80. doi: 10.1042/bj1950471.
3
Lack of binding of human C3, in its native state, to C3b receptors.天然状态下的人C3与C3b受体缺乏结合。
J Immunol. 1981 Oct;127(4):1329-34.
4
Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans.巨噬细胞Fc和C3b受体在免疫包被新型隐球菌吞噬作用中的作用。
Proc Natl Acad Sci U S A. 1981 Jun;78(6):3853-7. doi: 10.1073/pnas.78.6.3853.
5
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.特异性抗体在B族链球菌III型替代补体途径介导的调理吞噬作用中的作用
J Exp Med. 1980 May 1;151(5):1275-87. doi: 10.1084/jem.151.5.1275.
6
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.鉴定作为人类红细胞、多形核白细胞、B淋巴细胞和单核细胞C3b受体的膜糖蛋白。
J Exp Med. 1980 Jul 1;152(1):20-30. doi: 10.1084/jem.152.1.20.
7
Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.抗体可恢复经链霉蛋白酶预处理而功能缺陷的小鼠红细胞对人替代补体途径的激活作用。
J Immunol. 1982 Mar;128(3):1302-6.
8
IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.小鼠红细胞上的IgG通过增强C3b的沉积来增强人类替代补体途径的激活。
J Immunol. 1981 May;126(5):1805-9.
9
Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.补体C3中假定硫酯键与替代途径激活及C3b与补体生物学靶点结合的关系。
J Exp Med. 1980 Oct 1;152(4):1102-14. doi: 10.1084/jem.152.4.1102.
10
Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.低离子强度或单体C3b的化学交联会增加其与人补体C3b受体的结合亲和力。
Immunology. 1983 Feb;48(2):229-37.